Free Trial

NexgenRx Q4 2022 Earnings Report

C$0.25 -0.01 (-3.85%)
(As of 12/16/2024)

NexgenRx EPS Results

Actual EPS
-C$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NexgenRx Revenue Results

Actual Revenue
$3.38 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NexgenRx Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)

Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.

Click here to see Dan's full warning to the public.

NexgenRx Earnings Headlines

2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis
Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.
NexgenRX Inc.
Closing Bell: Nexgenrx Inc up on Monday (NXG)
See More NexgenRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NexgenRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NexgenRx and other key companies, straight to your email.

About NexgenRx

NexgenRx (CVE:NXG) administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.

View NexgenRx Profile

More Earnings Resources from MarketBeat

Upcoming Earnings